Gene mutant for controlling male sterility of tobacco and method for creating male sterility line of tobacco
The creation of tobacco male sterile lines through CRISPR/Cas9 gene editing and molecular marking technology has solved the problems of lack of materials and difficult to guarantee seed quality in tobacco breeding, and achieved efficient and low-cost breeding and seed purity control.
Patent Information
- Application Number
- CN202510568393.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-04-30
- Publication Date
- 2025-08-05
AI Technical Summary
The lack of excellent nuclear male sterile line materials in tobacco breeding makes it difficult to guarantee seed quality. Inbred line transplantation has problems of low purity and poor consistency, and traditional breeding methods are costly and inefficient. The application of modern molecular marking technology in tobacco breeding has not yet been fully utilized.
The two paralogic genes NtCYP704B1-T and NtCYP704B1-S of the tobacco male sterility-related gene NtCYP704B1 were simultaneously mutated by CRISPR/Cas9 gene editing technology, and the NtCYP704B1-T/S double-entangled sterile line was created, and molecular marker assisted breeding was used to perform molecular marker assisted breeding, and target single plants were screened.
The control of male sterility of tobacco is achieved, breeding efficiency and seed purity are improved, labor and material investment is reduced, and seed quality is ensured.